nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

07.08.2019 | Guidelines

EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy

verfasst von: Luca Giovanella, Anca M. Avram, Ioannis Iakovou, Jennifer Kwak, Susan A. Lawson, Elizabeth Lulaj, Markus Luster, Arnoldo Piccardo, Matthias Schmidt, Mark Tulchinsky, Frederick A. Verburg, Ely Wolin

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Scintigraphic evaluation of the thyroid gland enables determination of the iodine-123 iodide or the ^99mTc-pertechnetate uptake and distribution and remains the most accurate method for the diagnosis and quantification of thyroid autonomy and the detection of ectopic thyroid tissue. In addition, thyroid scintigraphy and radioiodine uptake test are useful to discriminate hyperthyroidism from destructive thyrotoxicosis and iodine-induced hyperthyroidism, respectively.

Methods

Several radiopharmaceuticals are available to help in differentiating benign from malignant cytologically indeterminate thyroid nodules and for supporting clinical decision-making. This joint practice guideline/procedure standard from the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) provides recommendations based on the available evidence in the literature.

Conclusion

The purpose of this practice guideline/procedure standard is to assist imaging specialists and clinicians in recommending, performing, and interpreting the results of thyroid scintigraphy (including positron emission tomography) with various radiopharmaceuticals and radioiodine uptake test in patients with different thyroid diseases.

Baker CH, Morris JC. The sodium-iodide symporter. Curr Drug Targets Immune Endocr Metabol Disord. 2004;4:167–74.CrossRef

Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 2003;24:48–77.CrossRef

Giovanella L, Ceriani L, Treglia G. Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:507–18.CrossRef

Giovanella L, Campenni A, Treglia G, Verburg FA, Trimboli P, Ceriani L, et al. Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging. 2016;43:1018–26.CrossRef

Treglia G, Caldarella C, Saggiorato E, Ceriani L, Orlandi F, Salvatori M, et al. Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 2013;44:70–8.CrossRef

Theissen P, Schmidt M, Ivanova T, Dietlein M, Schicha H. MIBI scintigraphy in hypofunctioning thyroid nodules--can it predict the dignity of the lesion? Nuklearmedizin. 2009;48:144–52.CrossRef

Treglia G, Bertagna F, Sadeghi R, Verburg FA, Ceriani L, Giovanella L. Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography. Nuklearmedizin. 2013;52(04):130–6.CrossRef

Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F, et al. (18)F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging. 2014;41:1482–91.CrossRef

Kusic Z, Becker DV, Saenger EL, Paras P, Gartside P, Wessler T, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J Nucl Med. 1990;31:393–9.PubMed

10.

Bongiovanni MPG, Ceriani L, Pusztaszeri M. Cellular and molecular basis for thyroid cancer imaging in nuclear medicine. Clin Transl Imaging. 2013;1:149–61.CrossRef

11.

Silberstein EB, Alavi A, Balon HR, Clarke SEM, Divgi C, Gelfand MJ, et al. The SNM practice guideline fof therapy of thyroid disease with ¹³¹I 3.0*. J Nucl Med. 2012;53:1633–51.CrossRef

12.

Hanscheid H, Canzi C, Eschner W, Flux G, Luster M, Strigari L, et al. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging. 2013;40:1126–34.CrossRef

13.

Piga M, Cocco MC, Serra A, Boi F, Loy M, Mariotti S. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol. 2008;159(4):423–9.CrossRef

14.

Pattison DA, Westcott J, Lichtenstein M, Toh HB, Gunawardana D, Better N, et al. Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis. Nucl Med Commun. 2015;36(4):356–62.CrossRef

15.

Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–95.CrossRef

16.

Schroder S, Marthaler B. Autonomy and malignancy of thyroid glad tumors. A critical analysis of the literature on the existence of hyperfunctioning follicular and papillary thyroid gland carcinomas. Pathologe. 1996;17(5):349–57.CrossRef

17.

Lupi A, Orsolon P, Cerisara D, Deantoni Migliorati G, Vianello Dri A. “Hot” carcinoma of the thyroid. Case reports and comments on the literature. Minerva Endocrinol. 2002;27(1):53–7.PubMed

18.

Schenke S, Seifert P, Zimny M, Winkens T, Binse I, Goerges R. Risk stratification of thyroid nodules using Thyroid Imaging Reporting and Data System (TIRADS): the omission of thyroid scintigraphy increases the rate of falsely suspected lesions. J Nucl Med. 2018.

19.

Giovanella L, D’Aurizio F, Campenni’ A, Ruggeri RM, Baldari S, Verburg FA, et al. Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions. Endocrine. 2016;54(3):757–61.CrossRef

20.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.CrossRef

21.

Musholt TJ, Clerici T, Dralle H, Frilling A, Goretzki PE, Hermann MM, et al. German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbeck's Arch Surg. 2011;396:639–49.CrossRef

22.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2010;16(Suppl 1):1–43.CrossRef

23.

Grant EG, Tessler FN, Hoang JK, Langer JE, Beland MD, Berland LL, et al. Thyroid ultrasound reporting lexicon: white paper of the ACR thyroid imaging, reporting and data system (TIRADS) committee. J Am Coll Radiol. 2015;12:1272–9.CrossRef

24.

Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27:1341–6.CrossRef

25.

Ross D. Evaluation and management of thyroid nodules with indeterminate cytology. Up to date. 2018. https://uptodate.com. Accessed Jan 6 2019

26.

Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705–15.CrossRef

27.

Alexander EK, Schorr M, Klopper J, Kim C, Sipos J, Nabhan F, et al. Multicenter clinical experience with the Afirma gene expression classifier. J Clin Endocrinol Metab. 2014;99:119–25.CrossRef

28.

Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomography (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol. 2007;14:3210–5.CrossRef

29.

de Koster EJ, de Geus-Oei LF, Dekkers OM, van Engen-van Grunsven I, Hamming J, Corssmit EPM, et al. Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules. Endocr Rev. 2018;39:154–91.CrossRef

30.

Klett M. Epidemiology of congenital hypothyroidism. Exp Clin Endocrinol Diabetes. 1997;105(Suppl 4):19–23.PubMed

31.

Clerc J, Monpeyssen H, Chevalier A, Amegassi F, Rodrigue D, Leger FA, et al. Scintigraphic imaging of paediatric thyroid dysfunction. Horm Res. 2008;70:1–13.CrossRef

32.

Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging. 2002;29:Suppl 2): 425–38.CrossRef

33.

Keller-Petrot I, Leger J, Sergent-Alaoui A, de Labriolle-Vaylet C. Congenital hypothyroidism: role of nuclear medicine. Semin Nucl Med. 2017;47:135–42.CrossRef

34.

ACR Practice Guidelines for Imaging Pregnant or Potentially Pregnant Adolescents and Women With Inonizing Radiation 2008 [Available from: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/Pregnant-Pts.pdf?la=en. Accessed May 30th, 2019).

35.

Lassmann M, Treves ST. Pediatric radiopharmaceutical administration: harmonization of the 2007 EANM Paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guideline. Eur J Nucl Med Mol Imaging. 2014;41:1636–041.CrossRef

36.

Gelfand MJ, Clements C, MacLean JR. Nuclear medicine procedures in children: special considerations. Semin Nucl Med. 2017;47:110–7.CrossRef

37.

Shimmins J, Alexander WD, McLarty DG, Robertson JW, Sloane DJ. 99mTc-pertechnetate for measuring thyroid suppressibility. J Nucl Med. 1971;12:51–4.PubMed

38.

Hurtado-Lopez LM, Martinez-Duncker C. Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules. Eur J Nucl Med Mol Imaging. 2007;34:1701–3.CrossRef

39.

Campenni A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, Baldari S, et al. Differentiating malignant from benign thyroid nodules with indeterminate cytology by (99m)Tc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017;7:6147.CrossRef

40.

Merten MM, Castro MR, Zhang J, Durski J, Ryder M. Examining the role of preoperative positron emission tomography/computerized tomography in combination with ultrasonography in discriminating benign from malignant cytologically indeterminate thyroid nodules. Thyroid. 2017;27:95–102.CrossRef

41.

Pak K, Kim SJ, Kim IJ, Kim BH, Kim SS, Jeon YK. The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery. Endocr Relat Cancer. 2013;20:203–13.CrossRef

42.

Piccardo A, Puntoni M, Treglia G, Foppiani L, Bertagna F, Paparo F, et al. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. Eur J Endocrinol. 2016;174:693–703.CrossRef

Titel: EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy
verfasst von: Luca Giovanella
Anca M. Avram
Ioannis Iakovou
Jennifer Kwak
Susan A. Lawson
Elizabeth Lulaj
Markus Luster
Arnoldo Piccardo
Matthias Schmidt
Mark Tulchinsky
Frederick A. Verburg
Ely Wolin
Publikationsdatum: 07.08.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04472-8

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy

Abstract

Introduction

Methods

Conclusion

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Methods

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET

Assessment of acute bone loading in humans using [18F]NaF PET/MRI

A guide for a brave future for lung ventilation/perfusion tomography: the most important pulmonary nuclear medicine technique

Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET

Cardiac pharmacologic stress: does the gender matters?

Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study